Drug intelligence / Profile preview

Heweiyangxue Huacai Formula

Development stage: Unknown
Administration: Oral

Overview

Heweiyangxue Huacai Formula is a traditional Chinese medicine (TCM) herbal compound under investigation for the treatment of cancer-related fatigue in patients with non-small cell lung cancer. The formula is being evaluated in a randomized controlled clinical trial to assess its efficacy and safety for this indication. As a TCM formulation, it likely contains multiple herbal ingredients designed to address symptoms such as fatigue, but the precise composition and mechanism of action are not specified in available sources. Its use reflects an integrative approach combining conventional oncology care with traditional medicine practices[1].

Brand names: Heweiyangxue Huacai Formula
Other names: Heweiyangxue Huacai Formula

Beyond the preview

Go deeper on Heweiyangxue Huacai Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heweiyangxue Huacai Formula.

Explore the full profile